Mindfulness-based online intervention on mental health and quality of life among COVID-19 patients in China: an intervention design

Author:

Si Ming-Yu,Xiao Wei-Jun,Pan Chen,Wang Hao,Huang Yi-Man,Lian Jun,Mak Winnie W. S.,Leng Zhi-Wei,Su Xiao-YouORCID,Tang Qiu-Ping,Jiang Yu,Feng Lu-Zhao,Yang Wei-Zhong,Wang Chen

Abstract

Abstract Background COVID-19 can lead to increased psychological symptoms such as post-traumatic stress disorder (PTSD), depression, and anxiety among patients with COVID-19. Based on the previous mindfulness-based interventions proved to be effective, this protocol reports a design of a randomized controlled trial aiming to explore the efficacy and possible mechanism of a mindful living with challenge (MLWC) intervention developed for COVID-19 survivors in alleviating their psychological problems caused by both the disease and the pandemic. Methods In April 2021, more than 1600 eligible participants from Hubei Province of China will be assigned 1:1 to an online MLWC intervention group or a waitlist control group. All participants will be asked to complete online questionnaires at baseline, post-program, and 3-month follow-up. The differences of mental health status (e.g. PTSD) and physical symptoms including fatigue and sleeplessness between the COVID-19 survivors who receiving the online MLWC intervention and the control group will be assessed. In addition, the possible mediators and moderators of the link between the MLWC intervention and target outcomes will be evaluated by related verified scales, such as the Five Facets Mindfulness Questionnaire. Data will be analyzed based on an intention-to-treat approach, and SPSS software will be used to perform statistical analysis. Discussion The efficacy and potential mechanism of MLWC intervention in improving the quality of life and psychological status of COVID-19 survivors in China are expected to be reported. Findings from this study will shed light on a novel and feasible model in improving the psychological well-being of people during such public health emergencies. Trial registration Chinese Clinical Trial Registry (ChiCTR), ChiCTR2000037524; Registered on August 29, 2020, http://www.chictr.org.cn/showproj.aspx?proj=60034.

Funder

The Innovative Engineering Program sponsored by the Chinese Academy of Medical Sciences

Asian Regional Special Cooperation Fund of National Health Commission of the People's Republic of China

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Medicine

Reference51 articles.

1. WHO. COVID-19 weekly epidemiological update, 21 March 2021. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---23-march-2021. Accessed 22 Mar 2021.

2. World Health Organization. 2020. Coronavirus disease 2019 (COVID-19): Situation report 63. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200323-sitrep-63-Covid-19.pdf?sfvrsn=d97cb6dd_2. Accessed 18 Nov 2020.

3. National Health Commission of the People’s Republic of China. March 23: Daily briefing on novel coronavirus cases in China. http://en.nhc.gov.cn/2021-03/23/c_83286.htm. Accessed 22 Mar 2021.

4. Luo M, Guo L, Yu M, Jiang W, Wang H. The psychological and mental impact of coronavirus disease 2019 (COVID-19) on medical staff and general public—a systematic review and meta-analysis. Psychiatry Res. 2020;291:113190. https://doi.org/10.1016/j.psychres.2020.113190.

5. Si MY, Su XY, Jiang Y, Wang WJ, Gu XF, Ma L, et al. Psychological impact of COVID-19 on medical care workers in China. Infect Dis Poverty. 2020;9(1):113. https://doi.org/10.1186/s40249-020-00724-0.

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3